Pfizer Achieves Double Firsts With AAHRPP Status For Phase I Trials In Singapore

SINGAPORE - Pfizer became the first pharma company to be accredited by the U.S.-based Association for the Accreditation of Human Research Protection Programs for its Phase I Clinical Research Unit in Singapore